Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children
- 1 January 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (1) , 62-69
- https://doi.org/10.1097/00006454-200301000-00016
Abstract
To evaluate the immune reconstitution in HIV-1-infected children in whom highly active antiretroviral therapy (HAART) controlled viral replication and to assess the existence of a relation between the magnitude of this restoration and age. All HIV-1-infected children in whom a new HAART decreased plasma viral load below 400 copies/ml after 3 months of therapy were prospectively enrolled in a study of their immune reconstitution. Viral load, lymphocyte phenotyping, determination of CD4+ and CD8+ T cell receptor repertoires and proliferative responses to mitogens and recall antigens were assessed every 3 months during 1 year. Nineteen children were evaluated. Naive and memory CD4+ percentages were already significantly increased after 3 months of HAART. In contrast to memory CD4+ percentages, naive CD4+ percentages continued to rise until 12 months. Age at baseline was inversely correlated with the magnitude of the rise in naive CD4+ cells after 3, 6 and 9 months of therapy but not after 12 months. Although memory and activated CD8+ cells were already decreasing after 3 months, abnormalities of the CD8 T cell receptor repertoire and activation of CD8+ cells persisted at 1 year. HAART increased the response to mitogens as early as 3 months after starting therapy. In children the recovery of naive CD4+ cells occurs more rapidly if treatment is started at a younger age, but after 1 year of viral replication control, patients of all ages have achieved the same level of restoration. Markers of chronic activation in CD8+ cells persist after 1 year of HAART.Keywords
This publication has 29 references indexed in Scilit:
- Long‐Term Protease Inhibitor–Containing Therapy Results in Limited Improvement in T Cell Function but Not Restoration of Interleukin‐12 Production in Pediatric Patients with AIDSThe Journal of Infectious Diseases, 2001
- The Dominant Source of CD4+ and CD8+ T-Cell Activation in HIV Infection Is Antigenic StimulationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Immunologic Response to Combination Nucleoside Analogue plus Protease Inhibitor Therapy in Stable Antiretroviral Therapy–Experienced Human Immunodeficiency Virus–Infected ChildrenThe Journal of Infectious Diseases, 2000
- Effect of HIV on Thymic Function before and after Antiretroviral Therapy in ChildrenThe Journal of Infectious Diseases, 2000
- In Vivo Expansion Coincident with Excessive in Vitro Cell Death within the Memory Subset of CD8+ T Cells in HIV Type 1 InfectionAIDS Research and Human Retroviruses, 1999
- Protease inhibitor and triple-drug therapyAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Progression of Human Immunodeficiency Virus Disease Is Associated with Increasing Disruptions within the CD4+T Cell Receptor RepertoireThe Journal of Infectious Diseases, 1998
- Detection of CD8 T-cell expansions with restricted T-cell receptor V gene usage in infants vertically infected by HIV-1AIDS, 1996
- Age-Related Changes in Human Blood Lymphocyte SubpopulationsClinical Immunology and Immunopathology, 1994